Fecal Microbiota Composition, Their Interactions, and Metagenome Function in US Adults with Type 2 Diabetes According to Enterotypes
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
T2DM etiology differs among Asians and Caucasians and may be associated with gut microbiota influenced by different diet patterns. However, the association between fecal bacterial composition, enterotypes, and T2DM susceptibility remained controversial. We investigated the fecal bacterial composition, co-abundance network, and metagenome function in US adults with T2DM compared to healthy adults based on enterotypes. We analyzed 1911 fecal bacterial files of 1039 T2DM and 872 healthy US adults from the Human Microbiome Projects. Operational taxonomic units were obtained after filtering and cleaning the files using Qiime2 tools. Machine learning and network analysis identified primary bacteria and their interactions influencing T2DM incidence, clustered into enterotypes, Bacteroidaceae (ET-B), Lachnospiraceae (ET-L), and Prevotellaceae (ET-P). ET-B showed higher T2DM incidence. Alpha-diversity was significantly lower in T2DM in ET-L and ET-P (p < 0.0001), but not in ET-B. Beta-diversity revealed a distinct separation between T2DM and healthy groups across all enterotypes (p < 0.0001). The XGBoost model exhibited high accuracy and sensitivity. Enterocloster bolteae, Facalicatena fissicatena, Clostridium symbiosum, and Facalibacterium prausnitizii were more abundant in the T2DM group than in the healthy group. Bacteroides koreensis, Oscillibacter ruminantium, Bacteroides uniformis, and Blautia wexlerae were lower in the T2DM than in the healthy group regardless of the enterotypes in the XGBoost model (p < 0.0001). However, the patterns of microbial interactions varied among different enterotypes affecting T2DM risk. The interaction between fecal bacteria was more tightly regulated in the ET-L than in the ET-B and ET-P groups (p < 0.001). Metagenomic analysis revealed an inverse association between bacteria abundance in T2DM, energy utility, butanoate and propanoate metabolism, and the insulin signaling pathway (p < 0.0001). In conclusion, fecal bacteria play a role in T2DM pathogenesis, particularly within different enterotypes, providing valuable insights into the link between gut microbiota and T2DM in the US population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They have also proven relevant in metabolic disorders like type 2 diabetes, in which Bacteroides-dominant enterotypes are correlated with higher metabolic risk profiles compared to Prevotella-dominant types, enabling targeted preventive or therapeutic interventions.172,173”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [172]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From local explanations to global understanding with explainable AI for trees
Lundberg, S. M., Erion, G., Chen, H., DeGrave, A., Prutkin, J. M., Nair, B., Katz, R., Himmelfarb, J., Bansal, N., & Lee, S.-I. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-019-0138-9 · Cited by 10,551 · cited 1×
“html (accessed on 8 June 2022) to separate the bacteria positively or negatively involved in the T2DM group using the output of the XGBoost model [38,39].”
Method(2012) · Cited by 8,009
Environmental and Gut Bacteroidetes: The Food Connection
Thomas, F., Hehemann, J.-H., Rebuffet, E., Czjzek, M., & Michel, G. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00093 · Cited by 1,337
Martin, C. R., Osadchiy, V., Kalani, A., & Mayer, E. A. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.04.003 · Cited by 1,284 · cited 1×
“The emerging evidence on the interconnectedness between the gut microbiome and host metabolism indicates that gut microbiota is associated with intestinal permeability, secretion of digestive juices, and the autonomous nervous system, all linked to the host’s genetic predisposition [15].”
BackgroundMa, R. C. W., & Chan, J. C. N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12098 · Cited by 827
Review: microbial transformations of human bile acids
Guzior, D. V., & Quinn, R. A. (2021) · Microbiome · doi:10.1186/s40168-021-01101-1 · Cited by 748
Qin, Y., Havulinna, A. S., Liu, Y., Jousilahti, P., Ritchie, S. C., Tokolyi, A., Sanders, J. G., Valsta, L., Brożyńska, M., Zhu, Q., et al. (2022) · Nature Genetics · doi:10.1038/s41588-021-00991-z · Cited by 586 · cited 2×
“Enterotypes are linked to not only the host’s genetic factors, but also diets [11,14,21,22].”
BackgroundRodrigues, V. F., Elias-Oliveira, J., Pereira, Í. S., Pereira, J. A., Barbosa, S. C., Machado, M. S. G., & Carlos, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.934695 · Cited by 407
Chen, Z., Radjabzadeh, D., Chen, L., Kurilshikov, A., Kavousi, M., Ahmadizar, F., Ikram, M. A., Uitterlinden, A. G., Zhernakova, A., Fu, J., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.18811 · Cited by 305 · cited 2×
“These bacteria were involved in butyrate production [28].”
BackgroundGut microbiota diversity across ethnicities in the United States
Brooks, A. W., Priya, S., Blekhman, R., & Bordenstein, S. R. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2006842 · Cited by 304 · cited 1×
“Several studies have reported a significant difference in the gut microbiota profiles across ethnicities in the US population [18].”
Background
Cited by
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Portincasa, P., Khalil, M., Graziani, A., Frühbeck, G., Baffy, G., Garruti, G., Ciaula, A. D., & Bonfrate, L. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.10.002 · Cited by 84
Han, X., Liu, Q., Li, Y., Zhang, M., Liu, K., Kwok, L.-Y., Zhang, H., & Zhang, W. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.104938 · Cited by 64
Yu, Y., Ding, Y., Wang, S., & Jiang, L. (2025) · Metabolites · doi:10.3390/metabo15060397 · Cited by 81
“Additionally, Alistipes was the genus found at a lower abundance in these patients [20].”
Yuan, H., Wu, X., Wang, X., Zhou, J., & Park, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042183 · Cited by 44
“The pre-trained naive Bayes classifier was specifically trained on Greengenes (revision 13.8), where the sequences were trimmed to include only 250 bases from the V4 hypervariable region of the 16S and pre-clustered at 99% sequence identity [54].”
BackgroundMethodInfluentialSelf-citationBeau, A., Benoit, B., Barz, M. L., Meugnier, E., Penhoat, A., Calzada, C., Pinteur, C., Loizon, E., Chanon, S., Vieille‐Marchiset, A., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2281015 · Cited by 34
Gut dysbiosis in oncology: a risk factor for immunoresistance
(2026) · doi:10.1038/s41422-025-01212-6 · Cited by 24
“172,173 In addition, enter-otypes can predict individual responses to probiotics, with metabolic improvements like reductions in blood glucose or triglycerides being enterotype-dependent.”
Zhu, X., Zhao, C.-Y., Meng, X.-Y., Yu, X., Ma, L.-C., Chen, T., Chang, C., Chen, X., Zhang, Y., Hou, B., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17081015 · Cited by 31
Rohmann, N., Geese, T., Nestel, S., Schlicht, K., Geisler, C., Türk, K., Brix, F., Jensen‐Kroll, J., Demetrowitsch, T. J., Bang, C., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03709-0 · Cited by 20
“Oscillibacter is known for its beneficial impact on the gut microbiome [57], and therefore, the findings suggest potential medical interventions such as smoking cessation and dietary adjustments to enhance its abundance.”
BackgroundMendis, B. I. L. M., Sarvananda, L., Jayasinghe, T. N., Rajapakse, I. H., & Dissanayake, A. S. (2025) · Medicine in Microecology · doi:10.1016/j.medmic.2025.100144 · Cited by 21
Geese, T., Bang, C., Franke, A., Lieb, W., & Dempfle, A. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04106-0 · Cited by 18
“So far, this application has been primarily explored in mice [85] and kelp [86], for instance, through the administration of prebiotics [87].”
Tourab, H., Lopez-Perez, L., Arroyo, P., Georga, E. I., Rujas, M., Ponziani, F. R., Torrego-Ellacuría, M., Barbancho, B. M., Dei, N. N., Ciuti, G., et al. (2025) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3593198 · Cited by 21
“…and interpretability of the used model, calculating mean absolute SHAP values to identify microbiome features impacting predictions most in CRC prediction [40], [41], autism spectrum disorder [42], [43], T2DM risk and states classification [44], [45], [46], treatment-related diarrhea risk in”
Bellanco, A., Celcar, Š., Martínez‐Cuesta, M. C., & Requena, T. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.114605 · Cited by 15
Han, Y., Quan, H., Ji, W., Tian, Q., Liu, X., & Liu, W. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150831 · Cited by 15
Son, S. J., Wu, X., Roh, H. W., Cho, Y. H., Hong, S., Nam, Y. J., Hong, C. H., & Park, S. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01820-9 · Cited by 21
“Bifidobacterium species are recognized probiotics capable of producing SCFAs through the fermentation of dietary fibers [27, 48].”
Self-citationSweeteners: erythritol, xylitol and cardiovascular risk—friend or foe?
Wölnerhanssen, B. K., Meyer‐Gerspach, A. C., Arduini, A., D’Alessandro, A., Gronda, E., Carugo, S., Bonomini, M., Gallieni, M. A., Masola, V., Angelillo‐Scherrer, A., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf091 · Cited by 14
“54,55 While a significant proportion of xylitol enters the colon, erythritol is mostly absorbed in the small intestine.”
Yuan, H., Zhou, J., Wu, X., Wang, S., & Park, S. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1568672 · Cited by 15
Self-citationZhong, Y., Deng, H., Zhao, J., Luo, G., & Li, H. (2024) · Medical Microbiology and Immunology · doi:10.1007/s00430-024-00796-x · Cited by 7
The Gut Gambit: A Review of How Microbial Imbalance Fuels Metabolic Mayhem
Venkata, L. N. S., Mishra, A. K., Mohanta, Y. K., Rustagi, S., Bahuguna, A., Tomar, A., Baek, K.-H., & Mishra, B. (2026) · Nutrients · doi:10.3390/nu18060888 · Cited by 9
“At the genus level, Asian people with T2DM exhibited fewer strains of Bacteroides , Faecalibacterium , and Blautia and higher percentages of Bifidobacterium , Streptococcus , and Prevotella than healthy controls [101].”
Special Issue: “Gut Microbiota and Nutrition in Human Health”
Park, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111589 · Cited by 6
Self-citationCAO, J., HE, Q., ZHANG, M., Zhou, R., & FENG, C. (2025) · Polish Journal of Microbiology · doi:10.33073/pjm-2025-011 · Cited by 4
“B. wexlerae is usually significantly reduced in the guts of patients with intestinal inflammatory and metabolic diseases (Benítez-Páez et al. 2020; Hu et al. 2021; Park et al. 2023), and a similar phenomenon has been observed in patients with IPA.”
Managing Glucose Homeostasis Through the Gut Microbiome
Weninger, S. N., Manley, A., & Duca, F. A. (2025) · Annual Review of Physiology · doi:10.1146/annurev-physiol-051524-094728 · Cited by 4
Du, Q., Fu, R., Zhao, M., & Xu, M. (2025) · Foods · doi:10.3390/foods14152557 · Cited by 5
“E. bolteae has been shown to be abundantly enriched in patients with T2D [46] and Chronic Hepatitis B [47] and may contribute to metabolic dysregulation by disrupting bile acid metabolism [48].”
Wang, J., Wei, Y., Chen, D., Li, X., Zhang, H., Feng, S., Lu, S., Yang, J., Zeng, Q., He, X., et al. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70283 · Cited by 1
“Furthermore, a large-sample study from the United States revealed a reduction in microbial α-diversity (e.g., Chao1 index) (Park et al. 2023), reflecting a general reduction in gut microbiota diversity in T2DM patients.”
Badnjević-Čengić, A., Škrbić, R., Softić, A., Bego, T., Meseldžić, N., Stojaković, N., Crnčević, N., Deumić, S., Kadić, D., Mooranian, A., et al. (2026) · Technology and Health Care · doi:10.1177/09287329261438698 · Cited by 1
Witkowski, M., Przybyciński, J., Wojciuk, B., Czaja, W., Gołembiewska, N., & Gołembiewska, E. (2026) · Acta Biochimica Polonica · doi:10.3389/abp.2026.16436 · Cited by 1
Biolcatti, C. F., Bóbbo, V. C. D., Solon, C., Morari, J., Haddad-Tóvolli, R., ARAUJO, E. P. D., Simoes, M. R., & Velloso, L. A. (2023) · Nutrients · doi:10.3390/nu15245041
“Studies have shown that Clostridia are commonly increased in the gut of animal models and humans with obesity [41,42].”
BackgroundDecoDiPhy: Deconvolving Phylogenetic Distance MixturesPreprint
Arasti, S., Şapcı, A. O. B., Rachtman, E., El-Kebir, M., & Mirarab, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.18.700179
Ding, L., Xi, Z., Zou, Y., Li, S., Chen, D., Liu, Y., & Zhao, J. (2026) · Current Diabetes Reviews · doi:10.2174/0115733998411102251127094217
Role of Gut Microbiota in Bridging Vitamin D Deficiency and Type 2 Diabetes Mellitus Pathogenesis
Zhan, Y., Liu, J., Di, Q., & Na, L. (2026) · Microorganisms · doi:10.3390/microorganisms14030628
Jia, S., Chen, P.-X., Wang, J.-L., Liu, W.-X., Wang, J.-T., Yin, W.-Q., & Lin, J. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1833646
Gut Microbial Dysbiosis in Type 2 Diabetes Patients with Concurrent Atherosclerosis
Sammad, A., Khan, S., Zhang, Y., Bai, X.-L., Zhu, X., & Yin, K. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01427-x · Cited by 1
Huang, D., Gao, Y., Hao, K., Hu, C., Zhang, S., Gong, W., Qin, X., Du, G., Li, H., & Zhou, Y. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101674
Diab, H. M., Kullberg, R. F. J., Yeo, L.-F., Wikki, I., Salomaa, V. V., Havulinna, A. S., Lahti, L., Pärnänen, K. M. M., Jalkanen, S., Salmi, M., et al. (2026) · mSystems · doi:10.1128/msystems.00645-26
EVALUATION OF THE INFLUENCE OF THE PROBIOTIC SUPPLEMENT ENTEROCOCCUS FAECIUM ON THE HUMAN INTESTINE
Морозова, П., Burakova, I. Y., Dmitrievna, S. Y., Pogorelova, S. V., Zvereva, O., Kryukova, O. N., Kislova, T., Korneeva, O., & Syromyatnikov, M. Y. (2026) · Problems of Biological Medical and Pharmaceutical Chemistry · doi:10.29296/25877313-2026-08-08
Bae, Y., Daily, J. W., & Park, S. (2026) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2026.151
“…been reported to be enriched in T2DM, although the direction and magnitude of association may vary across populations and may be influenced by differences in medication use, particularly metformin, as well as baseline dietary patterns and microbial ecology (Park et al., 2023; Kumar et al., 2026).”
Self-citation
Metadata
- Authors
- Park, S., Zhang, T., & Kang, S.
- Affiliations
- Hoseo University (KR)
- Corresponding author
- Park, Sunmin
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-05-31
- Volume
- 24
- Issue
- 11
- Pages
- 9533
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10253423
- OpenAlex
- W4379033625
- Cited by
- 35
- References
- 40
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 7 · 2023: 3
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Research Foundation of Korea (RS-2023-00208567)
- Ministry of Science and ICT (RS-2023-00208567)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, gut microbiota, enterotypes, co-abundance networks, Bacteroidaceae, Lachnospiraceae, Prevotellaceae, alpha and beta diversity, Enterocloster bolteae, insulin signaling pathway, diabetes risk
- MeSH terms
- Gastrointestinal Microbiome, Adult, Bacteria, Diabetes Mellitus, Type 2, Feces, Humans, Metagenome, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.